First Time Loading...

Minerva Neurosciences Inc
NASDAQ:NERV

Watchlist Manager
Minerva Neurosciences Inc Logo
Minerva Neurosciences Inc
NASDAQ:NERV
Watchlist
Price: 2.37 USD 0.85% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

NERV Price Targets Summary
Minerva Neurosciences Inc

Wall Street analysts forecast NERV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NERV is 11.22 USD with a low forecast of 11.11 USD and a high forecast of 11.55 USD.

NERV Lowest Forecast
Wall Street Target
11.11 USD
369% Upside
NERV Average Forecast
Wall Street Target
11.22 USD
373% Upside
NERV Highest Forecast
Wall Street Target
11.55 USD
387% Upside
Lowest
Price Target
11.11 USD
369% Upside
Average
Price Target
11.22 USD
373% Upside
Highest
Price Target
11.55 USD
387% Upside

NERV Last Price Targets
Minerva Neurosciences Inc

The latest public price target was made on May 2, 2024 by Douglas Tsao from H.C. Wainwright , who expects NERV stock to rise by 195% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Douglas Tsao
H.C. Wainwright
7 USD
Upside 195%
3 days ago
May 2, 2024
Minerva Neurosciences (NERV) PT Lowered to $7 at H.C. Wainwright
StreetInsider
Douglas Tsao
H.C. Wainwright
Price Target 7 USD
Upside/Downside 195%
View Source
Minerva Neurosciences Inc Competitors:
Price Targets
VCYT
Veracyte Inc
55% Upside
KOD
Kodiak Sciences Inc
15% Upside
SNSE
Sensei Biotherapeutics Inc
166% Upside
CYTH
Cyclo Therapeutics Inc
123% Upside
VCYT
Veracyte Inc
55% Upside
KOD
Kodiak Sciences Inc
15% Upside
SNSE
Sensei Biotherapeutics Inc
166% Upside
CYTH
Cyclo Therapeutics Inc
123% Upside
TSVT
2Seventy Bio Inc
136% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
28% Upside
I
IMRX
Immuneering Corp
710% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside

Revenue
Forecast

Revenue Estimate
Minerva Neurosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Minerva Neurosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Minerva Neurosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
NERV intrinsic value, competitors valuation, and company profile.
DCF Valuation
NERV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NERV stock valuation using valuation multiples.
Wall Street Estimates
NERV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NERV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NERV's stock price target?
Price Target
11.22 USD

According to Wall Street analysts, the average 1-year price target for NERV is 11.22 USD with a low forecast of 11.11 USD and a high forecast of 11.55 USD.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.